Insights

Recent articles, reports, and other media from Velocity

Exploring the Power of Scale in Patient Recruitment: A Recap of the Velocity and HealthMatch Presentation at SCOPE

March 26, 2024

Last month, Nick Spittal, Velocity’s chief operating officer announced the company’s latest partnership with HealthMatch and results from an unprecedented patient recruitment pilot at the SCOPE conference in Orland, Florida. He was joined by HealthMatch CEO, Manuri Gunawardena, on stage for a joint presentation, as Clinical Trials Report journalist Michael Causey reports: Velocity announced its … Read more

Video: AI-Enabled Technology

February 29, 2024

Despite a boom in tech funding and monumental advancements in AI/ML and in silico models, tech advancements have not yet translated into marked efficiency improvements at clinical research sites. Most clinical trials still fail to meet enrollment timelines, with most delays occurring at the site level. To gain efficiency, technology must enhance clinical trials at … Read more

Podcast: Celebrating Excellence in Patient Centricity (With Sanofi and SCRS)

February 27, 2024

“[Patient centricity] is about taking those patient insights and their voice and translating them into actions. And that was really the impetus for what we saw in Velocity’s submission.” – Pat Roselle, Global Head of Patient Stakeholder Engagement at Sanofi. Thank you to Pat and Jimmy Bechtel for joining Nick Spittal to discuss the initiatives … Read more

Video: Global Laboratory Capabilities

February 20, 2024

As part of our integrated site infrastructure, Velocity has established specialized laboratory and diagnostic capabilities. This includes purpose-built, CLIA-certified lab facilities at all dedicated sites, as well as in-network PBMC processing at 30+ Velocity locations across the U.S. and Europe. As Nick Spittal, Chief Operations Officer, explains in this video, Velocity is also using these … Read more

Video: Principal Investigator Experience and Engagement

February 9, 2024

About half of Principal Investigators (PIs) conduct only a single study in their career. This high turnover rate results in significant inefficiencies for Sponsors and CROs, particularly when it comes to finding reliable PIs capable of delivering high-quality trial conduct and enrollment in specialized research areas. Velocity developed the innovative Principal Investigator Onboarding and Training (PIVOT) … Read more

Video: Community Engagement

February 3, 2024

To bring equitable products to market, clinical trials need proportionate representation. Reaching the right patients must be prioritized at the site level, where clinical research is most visible in communities. Therefore, Velocity is heavily invested in leveraging the power of local influence to drive change. Our focus is on managing what we can effectively control … Read more

Video: Environmental Governance

January 19, 2024

As Nicholas Campbell explains, good business can also be good for the environment. As Velocity improves lives by accelerating the development of new therapies, we can also build a healthier tomorrow by conducting trials in a sustainable way. How can Velocity deliver more efficient trials? Enhanced site enrollment forecasting to minimize overages, alongside reduced investigational product distribution … Read more

Paul Evans, Nadege Gunn Featured in ACRP Trend Prediction Article

January 11, 2024

Paul Evans, President and CEO and Nadege Gunn, MD, CPI, Medical Director and Senior Scientific Advisor for Velocity are highlighted in a recent article by the ACRP, The Year Ahead in Trends, Challenges, and Opportunities for Clinical Trial Sites. In the article, Dr. Gunn shares her hope for Sponsors and CROs “to fund a long-term … Read more

Video: Demand and Delivery

January 9, 2024

Watch Christy Godwin and Laura Falcone discuss Velocity’s unique ‘Demand and Delivery’ approach. Christy and Laura work in unison to ensure full alignment among what Sponsors and CROs demand, and the quality, performance, and patient experiences Velocity delivers. In this video, they delve into: The importance of understanding goals and translating them into actionable strategies … Read more

Video: Scale for a Purpose

January 3, 2024

A staggering 80% of clinical trials are delayed or shut down due to enrollment challenges, with half of those delays occurring at the site level. Two-thirds of principal investigators leave research after conducting a single trial. It’s time for a change. Watch Paul Evans, Nick Campbell, Nick Spittal, and Craig Koch discuss Velocity’s unique model, … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Quality. Continuity. Velocity.